Cargando…

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976739/ https://www.ncbi.nlm.nih.gov/pubmed/36216362 http://dx.doi.org/10.1093/ndt/gfac257

Ejemplares similares

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
por: Gansevoort, Ron T., et al.
Publicado: (2016)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
por: Zoccali, Carmine, et al.
Publicado: (2023)

What should European nephrology do with the new CKD-EPI equation?
por: Gansevoort, Ron T, et al.
Publicado: (2022)

Proposed Statement by the CERN Council
Publicado: (1957)

Statement to the Council by the Director-General
Publicado: (1962)

Sex differences in arterial hypertension: A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy
por: Gerdts, Eva, et al.
Publicado: (2022)

CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council(✰)
por: Ayer, Julian, et al.
Publicado: (2020)

Clinical practice of cardiovascular magnetic resonance: position statement of the Society for Cardiovascular Magnetic Resonance
Publicado: (2019)

Statement by the President of the Council (Item 12 of the Agenda)
Publicado: (1969)

Prognostication in comatose survivors of cardiac arrest: An advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine
por: Sandroni, Claudio, et al.
Publicado: (2014)

CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic()
por: Wahi, Sudhir, et al.
Publicado: (2020)

Neuromodulation of chronic headaches: position statement from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2013)

A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy
por: Cabiddu, Gianfranca, et al.
Publicado: (2016)

Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)
por: Vanholder, Raymond, et al.
Publicado: (2010)

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy(†)
por: Fliser, Danilo, et al.
Publicado: (2012)

The European Research Council
por: König, Thomas
Publicado: (2017)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology
por: Attini, Rossella, et al.
Publicado: (2020)

Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH)
por: Sarafidis, Pantelis A, et al.
Publicado: (2023)

Aussie KIDS SAVE LIVES: A position statement from the Australian Resuscitation Council and supported by stakeholders
por: Bray, Janet, et al.
Publicado: (2021)

Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney
por: Vanholder, Raymond, et al.
Publicado: (2021)

The Routine Treatment of Eclampsia : Statement by the President
por: Lackie, J. Lamond
Publicado: (1923)

Guidelines of the Council on Environmental Quality for the preparation of environmental impact statements.
por: Willard, B E
Publicado: (1975)

Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)
por: Nensa, Felix, et al.
Publicado: (2018)

Global perspectives on heart disease rehabilitation and secondary prevention: a scientific statement from the Association of Cardiovascular Nursing and Allied Professions, European Association of Preventive Cardiology, and International Council of Cardiovascular Prevention and Rehabilitation
por: Taylor, Rod S, et al.
Publicado: (2023)

The European Research Council—A European Renaissance
por: O'Neill, Bill
Publicado: (2004)

Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology
por: Stompór, Tomasz, et al.
Publicado: (2023)

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
por: Harris, Tess, et al.
Publicado: (2018)

The European Society of Paediatric Radiology’s position statement on point-of-care ultrasound
por: Györgyi, Zoltán, et al.
Publicado: (2022)

Position statement and best practice recommendations on the imaging use of ultrasound from the European Society of Radiology ultrasound subcommittee
Publicado: (2020)

Fluorotechnology Is Critical to Modern Life: The FluoroCouncil Counterpoint to the Madrid Statement
por: Bowman, Jessica S.
Publicado: (2015)

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
por: Müller, Roman-Ulrich, et al.
Publicado: (2021)

European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Policy Document Development Strategy – Clinical Practice Guidelines, Position Statements and Technological Reviews
por: Jenssen, Christian, et al.
Publicado: (2019)

Diabetes and cardiovascular disease: from evidence to clinical practice – position statement 2014 of Brazilian Diabetes Society
por: Bertoluci, Marcello Casaccia, et al.
Publicado: (2014)

The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP)
por: Vanholder, Raymond, et al.
Publicado: (2009)

CERN, The European council for nuclear research
por: Amaldi, E
Publicado: (1955)

The position of renal denervation in treatment of hypertension: an expert consensus statement
por: Zeijen, V. J. M., et al.
Publicado: (2022)

Position Statements
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vbidm46g4mng2rd113dv82fouc